Navigation Links
MiMedx Group Announces Record First Quarter Results
Date:5/2/2012

the greatest contributors to our significant improvement in gross margins. We continue to receive excellent reception and interest among physicians as we market our allografts from our two amniotic tissue technology platforms, AmnioFix® and EpiFix®. In fact, we finished the first quarter with a strong surge of allograft orders that were fulfilled in the early part of the second quarter."

"During the first quarter of the year, we commenced the nationwide launch of AmnioFix® Injectable, our newest tissue offering," commented Bill Taylor, President and COO. "AmnioFix® Injectable is an allograft composed of micronized amniotic tissue that is injectable and offers surgeons a clear advantage due to its natural ability to reduce inflammation at the injection site and enhance soft tissue healing of micro-tears in tendon tissue. The initial reception for AmnioFix® Injectable has been very gratifying, and it should be a significant contributor to our continued growth. We are excited about the potential of our AmnioFix® technology and very pleased that the physicians doing procedures for the soft tissue trauma, nerve and tendon protection, spinal applications and sports medicine markets are embracing our offerings."

The Company also reported that it has received a positive preliminary decision for the Q-Code from the Centers for Medicare and Medicaid Services (CMS) for its EpiFix® allograft. If confirmed in November 2012, it will be effective January 1, 2013. In the fourth quarter of 2011, MiMedx was awarded the Epifix® C-Code. The Q-Code is the next step for MiMedx in the reimbursement process through CMS and another significant indicator in the acceptance by CMS of the uses of the Company's wound care allograft in treating Medicare patients with chronic wounds. The Q-Code will replace the C-Code and will be the foundation for EpiFix® reimbursement long term.

Balance Sheet and Other FinancialsThe Company
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. MiMedx Group Announces Temporary Trading Symbol Designation
2. MiMedx Group, Inc. to Present at Noble Financial Sixth Annual Equity Conference
3. MiMedx Group, Inc. Announces Release Date For Third Quarter Results
4. MiMedx Group, Inc. to Present at the 13th Annual Needham Growth Conference
5. MiMedx to Attend American Academy of Orthopedic Surgeons Annual Meeting
6. MiMedx Announces Launch of AmnioFix™
7. MiMedx Group, Inc. to Present at the 10th Annual Needham Healthcare Conference
8. MiMedx Group Announces 2010 Results
9. MiMedx Group Announces First Quarter 2011 Results
10. MiMedx Group, Inc. to Present at the Noble Financial Capital Markets Seventh Annual Equity Conference
11. MiMedx Group Completes $5,000,000 Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013) A million electric cars could be on roads ... the help of research by the United States Department of ... , Professor Zhongwei Chen is part of a team led ... materials to replace the expensive platinum catalysts in fuel cells. ... fuel cells in vehicles is the cost of the units. ...
(Date:6/18/2013)... USA (PRWEB) June 18, 2013 The ... the opening of two new offices in Asia—one in ... Singapore will serve as RAPS’ Pan-Asia office , ... will be more focused on audiences within China. , ... announced its partnership with five Singapore government agencies to ...
(Date:6/18/2013)... 18, 2013 Nasseo, Inc. today announces ... Winner out of hundreds of applicants by the ... Arizona Innovation Challenge . The Arizona Innovation Challenge (AIC) ... technology commercialization challenge, granting a financial award to what ... ventures. Nasseo’s state of the art dental and orthopedic ...
(Date:6/18/2013)... 2013 Edison Investment ... announces the initiation of full coverage of ... developing and marketing products for orphan oncology ...      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) Edison has ... investment merits of BioAlliance Pharma, focusing in ...
Breaking Biology Technology:US and Canadian researchers drive towards cheaper fuel cells for electric cars 2RAPS Opens Offices in Singapore and China 2RAPS Opens Offices in Singapore and China 3Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3
... May 1 Bio-Optronics announced Thursday,that a ... acquired by Dan Kerpelman,who will be joining ... CEO., Kerpelman brings over thirty years ... technology provider with headquarters,in Rochester, NY. The ...
... DermAvance Pharmaceuticals, a,privately held pharmaceutical company ... and cosmetic dermatology, today announced it,had received ... of,Southeastern Pennsylvania (BFTP/SEP). These funds are part ... used to complete the acquisition and,commercialization of ...
... Unveil State-of-the-Art Facility ... ... from Novavax,Inc. (Nasdaq: NVAX ), the State of Maryland ... vaccine production,facility at the company,s headquarters in Rockville, Maryland. The ...
Cached Biology Technology:Former GE, Kodak and SGS Executive Dan Kerpelman to Join Bio-Optronics as President and CEO 2DermAvance Pharmaceuticals Announces Investment by Ben Franklin Technology Partners of Southeastern Pennsylvania 2Novavax Opens Its First U.S. Vaccine Plant 2Novavax Opens Its First U.S. Vaccine Plant 3Novavax Opens Its First U.S. Vaccine Plant 4
(Date:6/17/2013)... high levels of air pollution while pregnant were up to ... women who lived in areas with low pollution, according to ... It is the first large national study to examine links ... findings raise concerns since, depending on the pollutant, 20% to ... where risk of autism was elevated," said lead author Andrea ...
(Date:6/17/2013)... An international team led by scientists at The ... and Albert Einstein College of Medicine of Yeshiva University ... attacks the tuberculosis (TB) bacterium in two different ways. ... one of the major global health crises of our ... said Peter G. Schultz, the Scripps Family Chair Professor ...
(Date:6/17/2013)... In research published in Biochemical and Biophysical Research ... that can detect new, previously unknown viruses. The technique ... when doctors have not identified a particular virus as ... In the new approach, scientists use blood serum as ... Taking advantage of the complete deciphering of the human ...
Breaking Biology News(10 mins):Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2New compound excels at killing persistent and drug-resistant tuberculosis 2New compound excels at killing persistent and drug-resistant tuberculosis 3New compound excels at killing persistent and drug-resistant tuberculosis 4Saint Louis University researchers discover a way to detect new viruses 2Saint Louis University researchers discover a way to detect new viruses 3
... Spanish . , A study by U.S. ... details about how fertilizing soils with biosolids also introduces ... the environment. Farmers add "Class B" biosolids, also ... a fertilizer. These biosolids meet federal regulations for human ...
... for many scientific studies. When you shine them on a ... loads of information about it. Unfortunately, this mostly applies to ... vacuum for the entire time it is being irradiated with ... all the water. In the case of biological samples such ...
... of acres of crops are planted throughout Africa, Asia and ... plant called Striga, also known as witchweed. It is ... and a team of scientists led by researchers from the ... break Striga,s stranglehold. When crops grow, their roots release ...
Cached Biology News:Tracking triclosan's field footprint 2LiXEdrom: Innovative measuring chamber for X-ray study of liquid jets 2
ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....
Rabbit Anti-Mouse Ym1 Polyclonal Antibody,...
ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....
... numbers of samples may be carried out using ... minimum operator attention. System control and data ... CE 4900. The elegant, powerful and very ... and Windows 98 and 2000., The supplied automatic ...
Biology Products: